INSIGHTS ON QUALITY ASSURANCE

• Handling Protocols: Key Considerations In The Highly Potent API Market

  Explore the growing role of highly potent active pharmaceutical ingredients in oncology and Antibody-Drug Conjugates to highlight manufacturing challenges, safety protocols, and opportunities for CDMOs.

• Beyond Visual Inspection: Understanding Acoustical Transparency As A PAT

  Airborne ultrasound enables non-destructive seal monitoring, detecting subtle material variations. See how this proactive approach enhances consistency, reduces risk, and ensures packaging integrity.

• MG America Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging

  Learn how to select the right containment solutions, explore technologies for encapsulated manufacturing, and identify critical phases in containment projects to protect operators and the environment.

• The Shift From CSV To CSA

  Explore current industry challenges, the urgent need to implement Computer System Assurance (CSA), and an approach to aid the pharmaceutical sector in understanding and embracing this essential shift.

• Nasal Inhalation Delivery – An Introduction Guide

  10/21/2024

  Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by exploring the benefits of both liquid and dry powder formulations as companies drive innovation in the field.

• How Can Data Translation Challenges In CRO Partnerships Be Overcome?

  1/29/2026

  Biopharma–CRO partnerships often struggle with fragmented communication. Gain insight into how streamlined, automated workflows improve transparency, data quality, and operational speed.

• Pressure Testing Your Readiness To Ensure GMP Batch #1 Success

  5/28/2024

  Watch as an expert from an industry-leading CDMO provides insights into the crucial factors, challenges, and tech transfer methods needed to achieve right-first-time readiness and success.

• The Importance Of Vendor And Supplier Quality Management

  9/20/2024

  Explore the importance of supplier quality management, relevant standards, regulatory audits, best practices, and the overall significance of this practice within the life sciences sector.

• Solve ATMP Aseptic Filling Challenges With Gloveless Isolators

  1/9/2026

  Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.